Skip to main content
TipRanks
Go Ultimate75% OFF

John Dunlop Insider Profile

4 Followers

John Dunlop, Director at Proteomics International Laboratories Ltd., holds 5.43M shares in Proteomics International Laboratories Ltd. (Ticker: AU:PIQ). Most recently, John Dunlop Bought 24,000 shares of Proteomics International Laboratories Ltd. on Jan 04, 2017 for an estimated value of AU$6.00K.

John Dunlop's Trading History

PIQ
Proteomics International Laboratories Ltd.
Jan 04, 2017DirectorInformative Buy6.00KAU$532.06K
AU:PIQ
Insider Shares: 5.43M (835.33%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 04, 2017Informative BuyAU$6.00K24,000AU$0.25+6.00%―
Dec 29, 2016Informative BuyAU$24.00K100,000AU$0.24+14.80%―

You May Also Like

John Dunlop insider profile FAQ

What is the percentage of profitable transactions made by John Dunlop?
The percentage of profitable transactions made by John Dunlop is 100%.
What is the average return per transaction made by John Dunlop?
The average return per transaction made by John Dunlop is 10.40%.
What stocks does John Dunlop hold?
John Dunlop holds: AU:PIQ stocks.
What was John Dunlop’s latest transaction?
John Dunlop’s latest transaction was an Informative Buy of AU$6.00K.
What was John Dunlop's most profitable transaction?
John Dunlop’s most profitable transaction was an Informative Buy of AU:PIQ stock on December 29, 2016. The return on the trade was 14.80%.
What is John Dunlop's role in Proteomics International Laboratories Ltd.?
John Dunlop's role in Proteomics International Laboratories Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.